HPL logo

Hoechst Pakistan Limited Stock Price

KASE:HPL Community·PK₨38.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author

HPL Share Price Performance

PK₨0
-3158.50 (-100.00%)
PK₨0
-3158.50 (-100.00%)
Price PK₨0

HPL Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Outstanding track record with flawless balance sheet and pays a dividend.

1 Risk
2 Rewards

Hoechst Pakistan Limited Key Details

PK₨31.0b

Revenue

PK₨19.6b

Cost of Revenue

PK₨11.3b

Gross Profit

PK₨8.4b

Other Expenses

PK₨2.9b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
300.69
36.55%
9.37%
0%
View Full Analysis

About HPL

Founded
1967
Employees
957
CEO
Sajjad Iftikhar
WebsiteView website
hoechst.com.pk

Hoechst Pakistan Limited, together with its subsidiary, manufactures, sells, and trades in pharmaceutical and related products in Pakistan, Afghanistan, and internationally. The company offers allergy management, anti-diarrheals, antibiotics, antiemetic, cardiology, consumer healthcare, diabetes, neurology, and emergency care products under various brand names, as well as vaccines. It exports its products. The company was formerly known as Sanofi-Aventis Pakistan Limited and changed its name to Hoechst Pakistan Limited in September 2023. Hoechst Pakistan Limited was incorporated in 1967 and is headquartered in Karachi, Pakistan.

Recent HPL News & Updates

Recent updates

No updates

Hoechst Pakistan Limited Competitors